These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10680808)

  • 1. Objective changes in motor function during placebo treatment in PD.
    Goetz CG; Leurgans S; Raman R; Stebbins GT
    Neurology; 2000 Feb; 54(3):710-4. PubMed ID: 10680808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease.
    Goetz CG; Leurgans S; Raman R;
    Mov Disord; 2002 Mar; 17(2):283-8. PubMed ID: 11921113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of Bushen Huoxue Granule on motor function in patients with Parkinson's disease: a multicenter, randomized, double-blind and placebo-controlled trial].
    Yang MH; Li M; Dou YQ; Liu Y; Luo XD; Chen JZ; Shi HJ
    Zhong Xi Yi Jie He Xue Bao; 2010 Mar; 8(3):231-7. PubMed ID: 20226144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease: improved function with GM1 ganglioside treatment in a randomized placebo-controlled study.
    Schneider JS; Roeltgen DP; Mancall EL; Chapas-Crilly J; Rothblat DS; Tatarian GT
    Neurology; 1998 Jun; 50(6):1630-6. PubMed ID: 9633704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions.
    Goetz CG; Wuu J; McDermott MP; Adler CH; Fahn S; Freed CR; Hauser RA; Olanow WC; Shoulson I; Tandon PK; ; Leurgans S
    Mov Disord; 2008 Apr; 23(5):690-9. PubMed ID: 18228568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
    Wills AM; Pérez A; Wang J; Su X; Morgan J; Rajan SS; Leehey MA; Pontone GM; Chou KL; Umeh C; Mari Z; Boyd J;
    JAMA Neurol; 2016 Mar; 73(3):321-8. PubMed ID: 26751506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn S;
    J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations.
    Tsang KL; Ho SL; Lo SK
    Neurology; 2000 Jun; 54(12):2292-8. PubMed ID: 10881255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
    Stocchi F; Rabey JM
    Eur J Neurol; 2011 Dec; 18(12):1373-8. PubMed ID: 21895884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
    Storch A; Jost WH; Vieregge P; Spiegel J; Greulich W; Durner J; Müller T; Kupsch A; Henningsen H; Oertel WH; Fuchs G; Kuhn W; Niklowitz P; Koch R; Herting B; Reichmann H;
    Arch Neurol; 2007 Jul; 64(7):938-44. PubMed ID: 17502459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations.
    Kroonenberg PM; Oort FJ; Stebbins GT; Leurgans SE; Cubo E; Goetz CG
    BMC Med Res Methodol; 2006 Jun; 6():26. PubMed ID: 16772027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Freezing of gait in PD: prospective assessment in the DATATOP cohort.
    Giladi N; McDermott MP; Fahn S; Przedborski S; Jankovic J; Stern M; Tanner C;
    Neurology; 2001 Jun; 56(12):1712-21. PubMed ID: 11425939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.
    Guttman M
    Neurology; 1997 Oct; 49(4):1060-5. PubMed ID: 9339690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of the placebo response in clinical trials on Parkinson's disease: A meta-analysis.
    Shin CW; Hahn S; Park BJ; Kim JM; Park EO; Jeon B
    Parkinsonism Relat Disord; 2016 Aug; 29():83-9. PubMed ID: 27237106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
    Parkinson Study Group
    Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in Language Function Correlates with Gait Improvement in Drug-naïve Parkinson's Disease Patients Taking Dopaminergic Medication.
    Murakami H; Momma Y; Nohara T; Mori Y; Futamura A; Sugita T; Ishigaki S; Katoh H; Kezuka M; Ono K; Miller MW; Kawamura M
    J Parkinsons Dis; 2016; 6(1):209-17. PubMed ID: 26889633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pergolide monotherapy in the treatment of early PD: a randomized, controlled study. Pergolide Monotherapy Study Group.
    Barone P; Bravi D; Bermejo-Pareja F; Marconi R; Kulisevsky J; Malagù S; Weiser R; Rost N
    Neurology; 1999 Aug; 53(3):573-9. PubMed ID: 10449123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial.
    Antonini A; Bauer L; Dohin E; Oertel WH; Rascol O; Reichmann H; Schmid M; Singh P; Tolosa E; Chaudhuri KR
    Eur J Neurol; 2015 Oct; 22(10):1400-7. PubMed ID: 26095948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.